1. Home
  2. WST vs KEY Comparison

WST vs KEY Comparison

Compare WST & KEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • KEY
  • Stock Information
  • Founded
  • WST 1923
  • KEY 1825
  • Country
  • WST United States
  • KEY United States
  • Employees
  • WST N/A
  • KEY N/A
  • Industry
  • WST Medical/Dental Instruments
  • KEY Major Banks
  • Sector
  • WST Health Care
  • KEY Finance
  • Exchange
  • WST Nasdaq
  • KEY Nasdaq
  • Market Cap
  • WST 18.9B
  • KEY 20.8B
  • IPO Year
  • WST N/A
  • KEY N/A
  • Fundamental
  • Price
  • WST $250.86
  • KEY $18.95
  • Analyst Decision
  • WST Buy
  • KEY Buy
  • Analyst Count
  • WST 7
  • KEY 16
  • Target Price
  • WST $332.50
  • KEY $19.72
  • AVG Volume (30 Days)
  • WST 501.4K
  • KEY 24.7M
  • Earning Date
  • WST 10-23-2025
  • KEY 10-16-2025
  • Dividend Yield
  • WST 0.35%
  • KEY 4.33%
  • EPS Growth
  • WST N/A
  • KEY N/A
  • EPS
  • WST 6.68
  • KEY 0.03
  • Revenue
  • WST $2,960,200,000.00
  • KEY $4,743,000,000.00
  • Revenue This Year
  • WST $6.28
  • KEY $76.36
  • Revenue Next Year
  • WST $6.02
  • KEY $6.10
  • P/E Ratio
  • WST $37.51
  • KEY $629.33
  • Revenue Growth
  • WST 2.90
  • KEY N/A
  • 52 Week Low
  • WST $187.43
  • KEY $12.73
  • 52 Week High
  • WST $352.33
  • KEY $20.04
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.03
  • KEY 57.46
  • Support Level
  • WST $241.64
  • KEY $18.69
  • Resistance Level
  • WST $248.66
  • KEY $19.50
  • Average True Range (ATR)
  • WST 4.85
  • KEY 0.34
  • MACD
  • WST -0.17
  • KEY 0.02
  • Stochastic Oscillator
  • WST 92.22
  • KEY 63.96

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About KEY KeyCorp

With assets of around $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

Share on Social Networks: